Patricia Imbach

765 total citations
11 papers, 587 citations indexed

About

Patricia Imbach is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Patricia Imbach has authored 11 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Genetics. Recurrent topics in Patricia Imbach's work include Ubiquitin and proteasome pathways (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). Patricia Imbach is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). Patricia Imbach collaborates with scholars based in Switzerland, United States and Austria. Patricia Imbach's co-authors include Pascal Furet, Hans‐Georg Capraro, Thomas Meyer, Carlos Garcı́a-Echeverrı́a, Johann Zimmermann, Donald Bierer, Diana M. Fort, Joane Litvak, Jian Luo and Marc Lang and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of Computer-Aided Molecular Design.

In The Last Decade

Patricia Imbach

11 papers receiving 564 citations

Peers

Countries citing papers authored by Patricia Imbach

Since Specialization

Citations

This map shows the geographic impact of Patricia Imbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Imbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Imbach more than expected).

Fields of papers citing papers by Patricia Imbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Imbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Imbach. The network helps show where Patricia Imbach may publish in the future.

Co-authorship network of co-authors of Patricia Imbach

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Imbach. A scholar is included among the top collaborators of Patricia Imbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Imbach. Patricia Imbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison 2010 ·Genes & Cancer ·(unknown), Johannes Roesel, Pascal Furet, Guido Bold, Patricia Imbach, Andreas Flörsheimer, Giorgio Caravatti, Jie Jiang, Paul W. Manley, Arghya Ray, James D. Griffin	33
2	The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis 2010 ·Angiogenesis ·Georg Martiny‐Baron, Philipp Holzer, Éric Billy, Christian Schnell, Joseph Brueggen, (unknown), Niko Schmiedeberg, Jeanette M. Wood, Pascal Furet, Patricia Imbach	105
3	Novel β-lactam derivatives: Potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome 2006 ·Bioorganic & Medicinal Chemistry Letters ·Patricia Imbach, Marc Lang, Carlos Garcı́a-Echeverrı́a, Vito Guagnano, (unknown), Johannes Roesel, Francis Bitsch, Grety Rihs, Pascal Furet	17
4	Entry into a New Class of Potent Proteasome Inhibitors Having High Antiproliferative Activity by Structure-Based Design 2004 ·Journal of Medicinal Chemistry ·Pascal Furet, Patricia Imbach, (unknown), (unknown), Kurt Laumen, Marc Lang, Vito Guagnano, Peter G. Fuerst, Johannes Roesel, Johann Zimmermann, Carlos Garcı́a-Echeverrı́a	51
5	Structure-Based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-Like activity of the human 20S proteasome 2002 ·Bioorganic & Medicinal Chemistry Letters ·Pascal Furet, Patricia Imbach, Peter G. Fuerst, Marc Lang, (unknown), Johann Zimmermann, Carlos Garcı́a-Echeverrı́a	22
6	Modeling of the Binding Mode of a Non-covalent Inhibitor of the 20S Proteasome. Application to Structure-Based Analogue Design 2001 ·Bioorganic & Medicinal Chemistry Letters ·Pascal Furet, Patricia Imbach, Peter Fürst, Marc Lang, (unknown), Johann Zimmermann, Carlos Garcı́a-Echeverrı́a	26
7	A New Structural Class of Selective and Non-covalent Inhibitors of the Chymotrypsin-like Activity of the 20S Proteasome 2001 ·Bioorganic & Medicinal Chemistry Letters ·Carlos Garcı́a-Echeverrı́a, Patricia Imbach, Dennis S. France, Peter Fürst, M. LANG, (unknown), Dieter Scholz, Johann Zimmermann, Pascal Furet	23
8	Structure-based design of potent CDK1 inhibitors derived from olomoucine 2000 ·Journal of Computer-Aided Molecular Design ·Pascal Furet, Juerg Zimmermann, Hans‐Georg Capraro, Thomas Meyer, Patricia Imbach	32
9	2,6,9-trisubstituted purines : Optimization towards highly potent and selective CDK1 inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·Patricia Imbach, Hans‐Georg Capraro, Pascal Furet, Helmut Mett, Thomas Meyer, J. Zimmermann	74
10	Ethnobotanical-Directed Discovery of the Antihyperglycemic Properties of Cryptolepine: Its Isolation from Cryptolepis sanguinolenta, Synthesis, and in Vitro and in Vivo Activities 1998 ·Journal of Medicinal Chemistry ·Donald Bierer, Diana M. Fort, (unknown), Jian Luo, Patricia Imbach, L. G. DUBENKO, Shivanand D. Jolad, (unknown), Joane Litvak, Qing Lü, (unknown), Michael Reed, Nancy Waldeck, Reimar C. Bruening, (unknown), Richard F. Hector, Thomas J. Carlson, Steven R. King	117
11	Antihyperglycemic Activities of Cryptolepine Analogues: An Ethnobotanical Lead Structure Isolated fromCryptolepis sanguinolenta 1998 ·Journal of Medicinal Chemistry ·Donald Bierer, L. G. DUBENKO, (unknown), Qing Lü, Patricia Imbach, Albert W. Garofalo, Puay‐Wah Phuan, Diana M. Fort, Joane Litvak, (unknown), (unknown), Jian Luo, Raymond Cooper, Gerald M. Reaven	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact